Milena Gianfrancesco, PhD, MPH

Assistant Professor

BS, - Neuroscience; Italian Studies, Brown University
PhD, - Epidemiology; Designated Emphasis in Computational and Genomic Biology, University of California, Berkeley
MPH, - Chronic Disease Epidemiology, Yale University
Honors and Awards
  • Career Development Bridge Funding Award: K Supplement, Rheumatology Research Foundation, 2020
  • NIH Loan Repayment Program, National Institutes of Health, NIAMS, 2017
  • Lawren H. Daltroy Health Professional Preceptorship, Rheumatology Research Foundation, 2017
  1. Rheumatology Informatics System for Effectiveness (RISE) Practices See Significant Gains in Rheumatoid Arthritis Quality Measures.
  2. Rheumatic disease activity, glucocorticoid use and COVID-19. Response to: 'Comment on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported re
  3. Epidemiology and outcomes of novel coronavirus 2019 in patients with immune-mediated inflammatory diseases.
  4. Minimum information about clinical artificial intelligence modeling: the MI-CLAIM checklist.
  5. COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the C
  6. More on Covid-19 in Immune-Mediated Inflammatory Diseases.
  7. Reweighting to address nonparticipation and missing data bias in a longitudinal electronic health record study.
  8. Response to: 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis' by Györfi et al.
  9. Mortality among Hospitalized Individuals with Systemic Lupus Erythematosus in the United States between 2006 and 2016.
  10. Patients with systemic lupus erythematosus using hydroxychloroquine or chloroquine develop severe COVID-19 at similar frequency as patients not on antimalarials: need to explore antithrombotic benefits for COVID-19 coagulopathy. Response to: 'Clinical cou
  11. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
  12. Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.
  13. Initial data from the COVID-19 Global Rheumatology Alliance provider registries - Authors' reply.
  14. Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries.
  15. Three Quality Improvement Initiatives Improved Performance of Rheumatoid Arthritis Disease Activity Measures in Electronic Health Records: Results from an Interrupted Time Series Study.
  16. A phenotypic and genomics approach in a multi-ethnic cohort to subtype systemic lupus erythematosus.
  17. Effects of language, insurance and race/ethnicity on measurement properties of the PROMIS Physical Function Short Form 10a in rheumatoid arthritis.
  18. Does early high body mass index influence onset of pediatric multiple sclerosis?
  19. Differences in Longitudinal Disease Activity Between Research Cohort and Noncohort Participants with Rheumatoid Arthritis Using Electronic Health Record Data.
  20. Increased risk of ischemic stroke in systemic sclerosis: a national cohort study of US veterans.
  21. Assessment of a Deep Learning Model Based on Electronic Health Record Data to Forecast Clinical Outcomes in Patients With Rheumatoid Arthritis.
  22. Gaps in Ambulatory Patient Safety for Immunosuppressive Specialty Medications.
  23. Smoking Is Associated with Higher Disease Activity in Rheumatoid Arthritis: A Longitudinal Study Controlling for Time-varying Covariates.
  24. Pneumocystis jirovecii pneumonia (PJP) prophylaxis patterns among patients with rheumatic diseases receiving high-risk immunosuppressant drugs.
  25. Potential Biases in Machine Learning Algorithms Using Electronic Health Record Data.
  26. Incorporating machine learning approaches to assess putative environmental risk factors for multiple sclerosis.
  27. Capturing a Patient-Reported Measure of Physical Function Through an Online Electronic Health Record Patient Portal in an Ambulatory Clinic: Implementation Study.
  28. The impact of smoking on disease measures in rheumatoid arthritis: the need for appropriate adjustment of time-varying confounding.
  29. Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritis.
  30. Genetic risk factors for pediatric-onset multiple sclerosis.
  31. Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety.
  32. The interaction between smoking and HLA genes in multiple sclerosis: replication and refinement.
  33. The price of whole-genome sequencing may be decreasing, but who will be sequenced?
  34. Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS.
  35. Causal Effect of Genetic Variants Associated With Body Mass Index on Multiple Sclerosis Susceptibility.
  36. Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk.
  37. Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies.
  38. Genetic risk and longitudinal disease activity in systemic lupus erythematosus using targeted maximum likelihood estimation.
  39. High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies.
  40. Obesity and Multiple Sclerosis Susceptibility: A Review.
  41. Obesity during childhood and adolescence increases susceptibility to multiple sclerosis after accounting for established genetic and environmental risk factors.
  42. Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis.
  43. Speed- and cane-related alterations in gait parameters in individuals with multiple sclerosis.
  44. Reduction of freezing of gait in Parkinson's disease by repetitive robot-assisted treadmill training: a pilot study.